ID29226A - Sediaan farma si yang berisi satu siklopeptida dan satu agen kemoterapi atau satu penghambat angiogenesis - Google Patents

Sediaan farma si yang berisi satu siklopeptida dan satu agen kemoterapi atau satu penghambat angiogenesis

Info

Publication number
ID29226A
ID29226A IDW20010746A ID20010746A ID29226A ID 29226 A ID29226 A ID 29226A ID W20010746 A IDW20010746 A ID W20010746A ID 20010746 A ID20010746 A ID 20010746A ID 29226 A ID29226 A ID 29226A
Authority
ID
Indonesia
Prior art keywords
cycopeptide
farma
objector
angiogenesis
size
Prior art date
Application number
IDW20010746A
Other languages
English (en)
Indonesian (id)
Inventor
Alfred Jonczyk
Astrid Perschl
Simon Goodman
Sigrid Resener
Jutta Haunschild
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ID29226A publication Critical patent/ID29226A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20010746A 1998-09-16 1999-09-09 Sediaan farma si yang berisi satu siklopeptida dan satu agen kemoterapi atau satu penghambat angiogenesis ID29226A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19842415A DE19842415A1 (de) 1998-09-16 1998-09-16 Pharmazeutische Zubereitung

Publications (1)

Publication Number Publication Date
ID29226A true ID29226A (id) 2001-08-16

Family

ID=7881169

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010746A ID29226A (id) 1998-09-16 1999-09-09 Sediaan farma si yang berisi satu siklopeptida dan satu agen kemoterapi atau satu penghambat angiogenesis

Country Status (31)

Country Link
US (1) US6683051B1 (es)
EP (2) EP1466615B1 (es)
JP (2) JP2002524526A (es)
KR (1) KR100703253B1 (es)
CN (2) CN1201812C (es)
AR (2) AR022382A1 (es)
AT (2) ATE432707T1 (es)
AU (1) AU765073B2 (es)
BR (1) BR9913737A (es)
CA (1) CA2344151A1 (es)
CO (1) CO5140070A1 (es)
CZ (1) CZ302908B6 (es)
DE (3) DE19842415A1 (es)
DK (2) DK1466615T3 (es)
ES (2) ES2241363T3 (es)
HU (1) HUP0103521A3 (es)
ID (1) ID29226A (es)
IL (2) IL141516A0 (es)
MY (1) MY129572A (es)
NO (1) NO331734B1 (es)
NZ (1) NZ510040A (es)
PE (1) PE20001046A1 (es)
PL (1) PL201902B1 (es)
PT (2) PT1113809E (es)
RU (1) RU2227041C2 (es)
SI (1) SI1113809T1 (es)
SK (1) SK287012B6 (es)
TR (1) TR200100765T2 (es)
TW (1) TW576744B (es)
WO (1) WO2000015244A2 (es)
ZA (1) ZA200103073B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7740841B1 (en) * 2000-01-28 2010-06-22 Sunnybrook Health Science Center Therapeutic method for reducing angiogenesis
CA2436326C (en) * 2001-01-09 2012-08-14 Merck Patent Gesellschaft Mit Beschraenkter Haftung Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
WO2003074045A1 (fr) * 2002-03-05 2003-09-12 Eisai Co., Ltd. Agent antitumoral comprenant une combinaison d'un compose heterocyclique contenant un sulfamide et d'un inhibiteur d'angiogenese
PL1734996T3 (pl) 2004-04-02 2013-09-30 Univ California Sposoby i kompozycje do leczenia i profilaktyki choroby związanej z integryną alfa v beta 5
NZ567837A (en) * 2005-11-02 2011-11-25 Univ Texas Concurrent chemotherapy and immunotherapy with EGFRvIII peptide and temozolomide
EP2338518A1 (en) * 2006-01-18 2011-06-29 Merck Patent GmbH Specific therapy using integrin ligands for treating cancer
US20110165150A1 (en) * 2006-01-18 2011-07-07 Merck Patent Gmbh Isolated organ perfusion combination therapy of cancer
MX2009007597A (es) 2007-01-18 2009-07-22 Merck Patent Gmbh Terapia especifica y medicamento que utilizan ligandos de integrina para tratar el cancer.
BRPI0815567B8 (pt) 2007-07-17 2021-05-25 Merck Patent Gessellschaft Mit Beschraenkter Haftung anticorpos híbridos anti-alfa v-integrina projetados, proteína de fusão e composição farmacêutica
WO2010051667A1 (zh) * 2008-11-10 2010-05-14 复旦大学 一种环肽纳米管药物组合物及其应用
CN102223915A (zh) * 2008-11-20 2011-10-19 默克专利有限公司 应用整联蛋白配体治疗癌症的新疗法和药物
BRPI1011206A2 (pt) 2009-05-25 2016-03-15 Merck Patent Gmbh administração contínua de ligantes de integrina para tratar câncer
KR101752515B1 (ko) 2009-07-24 2017-06-29 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 Avb5 인테그린과 결부된 질환의 치료 및 예방을 위한 방법 및 조성물
CN102652015B (zh) 2009-12-10 2016-08-03 默克专利有限公司 包含寡肽、优选西仑吉肽的药物组合物
EP2593122A1 (en) 2010-07-16 2013-05-22 Merck Patent GmbH Peptide for use in the treatment of breast cancer and/or bone metastases
WO2012069149A1 (en) 2010-11-23 2012-05-31 Merck Patent Gmbh Solution comprising cyclic oligopeptides
EP3415162A1 (en) 2011-02-11 2018-12-19 Merck Patent GmbH Anti-alpha-v integrin antibody for the treatment of prostate cancer
WO2012110200A1 (en) * 2011-02-18 2012-08-23 Merck Patent Gmbh Cyclic peptide cyclo (l -arginyl - glycyl - l -aspartyl - d - phenylalanyl - n-methyl - l -valyl), compositions thereof, and use thereof in methods for treating graft -versus - host disease
CN103717205B (zh) 2011-06-09 2017-04-12 默克专利股份公司 用西仑吉肽在载体中的悬浮液治疗癌症和癌症转移
WO2013130775A1 (en) * 2012-03-01 2013-09-06 Dizerega, Gere, S. Methods for treating patients undergoing multi-cycle chemotherapy
CN103333227B (zh) * 2013-06-07 2015-10-07 东南大学 转移肿瘤缺失蛋白小分子环肽抑制剂及其制备方法与应用
WO2018046610A1 (en) 2016-09-08 2018-03-15 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for diagnosing and treating nephrotic syndrome
JP2019208422A (ja) * 2018-06-04 2019-12-12 コリア・インスティテュート・オブ・サイエンス・アンド・テクノロジー ヒアルロニダーゼを含む新規な組換えエキソソーム及びその用途
GB201911816D0 (en) * 2019-08-16 2019-10-02 Univ London Queen Mary Treatment
GB202103122D0 (en) * 2021-03-05 2021-04-21 Univ London Queen Mary Treatment

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04367367A (ja) 1991-06-11 1992-12-18 Nkk Corp ロータリノズル
AU674553B2 (en) 1992-10-14 1997-01-02 Merck & Co., Inc. Fibrinogen receptor antagonists
CA2150550A1 (en) 1992-12-01 1994-06-09 Melissa S. Egbertson Fibrinogen receptor antagonists
CA2190870A1 (en) 1994-05-27 1995-12-07 George D. Hartman Compounds for inhibiting osteoclast-mediated bone resorption
EP0762882A4 (en) 1994-06-29 2002-09-11 Smithkline Beecham Corp Vibronectin Receptor Antagonists
WO1996000730A1 (en) 1994-06-29 1996-01-11 Smithkline Beecham Corporation Vitronectin receptor antagonists
ES2123889T3 (es) 1994-11-02 1999-01-16 Merck Patent Gmbh Antagonistas de receptores de adhesion.
DE19534177A1 (de) * 1995-09-15 1997-03-20 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
DE19548709A1 (de) * 1995-12-23 1997-07-03 Merck Patent Gmbh Tyrosinderivate
JPH09208571A (ja) * 1996-02-02 1997-08-12 Takeda Chem Ind Ltd アルキリデンシクロヘキサン誘導体
AU2438297A (en) * 1996-05-09 1997-11-26 Alcon Laboratories, Inc. Combinations of angiostatic compounds
US5919815A (en) * 1996-05-22 1999-07-06 Neuromedica, Inc. Taxane compounds and compositions
DE69739907D1 (de) 1996-05-31 2010-07-22 Scripps Research Inst 3 vermittelter angiogenesis hemmers
JPH1081631A (ja) * 1996-07-17 1998-03-31 Takeda Chem Ind Ltd 癌転移または再発抑制剤
DE19629816A1 (de) 1996-07-24 1998-01-29 Hoechst Ag Neue Cycloalkyl-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
DE19629817A1 (de) 1996-07-24 1998-01-29 Hoechst Ag Neue Imino-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
UA60311C2 (uk) 1996-10-02 2003-10-15 Смітклайн Бічам Корпорейшн Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція
CA2277273C (en) 1997-01-17 2008-03-25 Merck & Co., Inc. Integrin antagonists
DE19850131A1 (de) 1998-10-30 2000-05-04 Merck Patent Gmbh Chromenon- und Chromanonderivate

Also Published As

Publication number Publication date
HUP0103521A2 (hu) 2002-02-28
RU2227041C2 (ru) 2004-04-20
ATE292470T1 (de) 2005-04-15
DK1113809T3 (da) 2005-08-08
JP2011252012A (ja) 2011-12-15
IL141516A0 (en) 2002-03-10
SK287012B6 (sk) 2009-09-07
CN100352494C (zh) 2007-12-05
EP1466615A1 (de) 2004-10-13
CO5140070A1 (es) 2002-03-22
ES2241363T3 (es) 2005-10-16
CA2344151A1 (en) 2000-03-23
DE59911881D1 (de) 2005-05-12
NZ510040A (en) 2003-12-19
SI1113809T1 (en) 2005-10-31
SK3372001A3 (en) 2001-11-06
HUP0103521A3 (en) 2002-05-28
NO20011308D0 (no) 2001-03-15
CN1201812C (zh) 2005-05-18
NO20011308L (no) 2001-03-15
PL348026A1 (en) 2002-05-06
AU765073B2 (en) 2003-09-11
KR100703253B1 (ko) 2007-04-03
DE59915033D1 (de) 2009-07-16
PL201902B1 (pl) 2009-05-29
AR078175A2 (es) 2011-10-19
CZ2001932A3 (cs) 2001-09-12
EP1466615B1 (de) 2009-06-03
PE20001046A1 (es) 2000-10-14
IL141516A (en) 2009-09-22
DE19842415A1 (de) 2000-03-23
WO2000015244A3 (de) 2000-06-22
TW576744B (en) 2004-02-21
NO331734B1 (no) 2012-03-12
ES2327331T3 (es) 2009-10-28
EP1113809A2 (de) 2001-07-11
WO2000015244A2 (de) 2000-03-23
KR20010073155A (ko) 2001-07-31
US6683051B1 (en) 2004-01-27
ATE432707T1 (de) 2009-06-15
TR200100765T2 (tr) 2001-08-21
CZ302908B6 (cs) 2012-01-18
AU5975899A (en) 2000-04-03
PT1113809E (pt) 2005-08-31
MY129572A (en) 2007-04-30
DK1466615T3 (da) 2009-08-31
ZA200103073B (en) 2002-08-21
JP2002524526A (ja) 2002-08-06
CN1636590A (zh) 2005-07-13
AR022382A1 (es) 2002-09-04
PT1466615E (pt) 2009-09-07
CN1329499A (zh) 2002-01-02
BR9913737A (pt) 2001-06-05
EP1113809B1 (de) 2005-04-06

Similar Documents

Publication Publication Date Title
ID29226A (id) Sediaan farma si yang berisi satu siklopeptida dan satu agen kemoterapi atau satu penghambat angiogenesis
DE69811357D1 (de) Brausezusammensetzungen sowie trockene brausegranulate
NO954276L (no) Surgjöring av underjordiske reservoarer
HUP9902000A3 (en) Combination of materials for the low temperature triggering of the activation of getter materials and getter devices containing the same
NO981099L (no) Vannbaserte sammensetninger for tetning av underjordiske soner samt fremgangsmÕter
ID20586A (id) Skeloroglukan baru dan komposisi kosmetik yang mengandung senyawa baru
MX220980B (en) Cementing compositions and use of such compositions for cementing oil wells or the like
ID24839A (id) Senyawa-senyawa triazol dan penggunaannya
HUP9900812A3 (en) Thermally stabilized contrast agent
ID16856A (id) Turunan-turunan indazol yang disubstitusi dan senyawa-senyawa yang berhubungan
ID26945A (id) Komposisi farmasi yang mengandung misel yang terdiri dari glukokortikosteroid lipofilik dan hanya satu surfaktan
ID26402A (id) Amida-amida tersubstitusi yang baru, pembuatan dan penggunaannya
ID16517A (id) Metode dan peralatan sumur untuk kerikil yang membungkus sumur yang menggunakan cairan kepekatan rendah
GB2326895B (en) Seperation of oil-well fluid mixtures
PL340838A1 (en) Application of the renin-angiotensin system inhibitors
PL334517A1 (en) Clavulate and one or more of exicipients containing granules
GT200000143A (es) Empleo de formulaciones que contienen polisiloxano y agente deslizante de cadenas.
ID28382A (id) Bahan anti keringat dan komposisi-komposisi yang mengandung bahan anti keringat
ZA949928B (en) Breaking up of rock and the like
EE04703B1 (et) Migreeni kordumise ärahoimine
DE69808069D1 (de) Hypochlorithaltige bleichmittelzusammensetzungen und freisetzungssysteme dafür
ID28640A (id) Serbuk magnit dan magnit yang diikat isotrop
HUP9900476A3 (en) Blockbrick for building of drywall, and made of blockbrick drywall
ID29511A (id) Pemasangan kaitan yang digunakan untuk mekanisme penyesuaian-pinggang pada pakaian dan pakaian yang mempunyai mekanisme penyesuaian-pinggang
ID21840A (id) Turunan-turunan oksopiperazinil dan komposisi-komposisi yang distabilkan terhadap cahaya